JFS Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4K | Hold |
35
| – | – | ﹤0.01% | 825 |
|
|
2025
Q1 | $9.45K | Buy |
35
+9
| +35% | +$2.43K | ﹤0.01% | 896 |
|
|
2024
Q4 | $6.12K | Buy |
26
+2
| +8% | +$471 | ﹤0.01% | 1050 |
|
|
2024
Q3 | $6.6K | Buy |
24
+3
| +14% | +$825 | ﹤0.01% | 1015 |
|
|
2024
Q2 | $5.1K | Hold |
21
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q1 | $3.14K | Buy |
21
+6
| +40% | +$897 | ﹤0.01% | 1280 |
|
|
2023
Q4 | $2.87K | Sell |
15
-11
| -42% | -$2.11K | ﹤0.01% | 1274 |
|
|
2023
Q3 | $4.61K | Buy |
26
+5
| +24% | +$886 | ﹤0.01% | 1020 |
|
|
2023
Q2 | $3.99K | Buy |
21
+8
| +62% | +$1.52K | ﹤0.01% | 1100 |
|
|
2023
Q1 | $2.61K | Sell |
13
-11
| -46% | -$2.2K | ﹤0.01% | 1268 |
|
|
2022
Q4 | $5.7K | Hold |
24
| – | – | ﹤0.01% | 940 |
|
|
2022
Q3 | $5K | Buy |
24
+14
| +140% | +$2.92K | ﹤0.01% | 959 |
|
|
2022
Q2 | $1K | Sell |
10
-5
| -33% | -$500 | ﹤0.01% | 1452 |
|
|
2022
Q1 | $2K | Buy |
15
+5
| +50% | +$667 | ﹤0.01% | 1363 |
|
|
2021
Q4 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 1018 |
|